Status:

ACTIVE_NOT_RECRUITING

Adapting and Evaluating a Brief Advice Tobacco Intervention in High-Reach, Low-Resource Settings in India

Lead Sponsor:

Harvard School of Public Health (HSPH)

Collaborating Sponsors:

Dana-Farber Cancer Institute

Narotam Sekhsaria Foundation, India

Conditions:

Tobacco Use Cessation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study aims to promote tobacco cessation among adults in high-reach, low-resource community settings in Mumbai, India. Tobacco use is a major driver of cancer deaths and as of 2017, about 267 mill...

Detailed Description

Background and Significance: About 1 million deaths are attributed to tobacco use in India each year. In 2017 there were roughly 267 million tobacco users including 199 million smokeless tobacco user...

Eligibility Criteria

Inclusion

  • Practitioner inclusion criteria:
  • targeted workers from targeted settings
  • sufficient language proficiency in English and/or Hindi to attend the training and take surveys
  • has not received prior in-depth LifeFirst training
  • can recruit 10-60 tobacco users in a six-month period
  • works in a setting in which brief advice can be added to the workflow
  • delivers care in Greater Mumbai and expects to do so for one year post-training
  • can secure institutional signoff to participate and utilize the program in practice
  • has an Android smartphone
  • Patient inclusion criteria:
  • user of smokeless and / or smoked tobacco
  • age 18 and over
  • attending the practice of an enrolled practitioner
  • has a mobile phone (required for data collection)
  • does not have another member of their household participating in the study
  • is not currently participating in any tobacco cessation program (such as through the National Quitline)

Exclusion

  • Practitioner exclusion criteria:
  • does not work in one of the targeted settings
  • works in one of the targeted settings but is not a targeted worker
  • does not have sufficient language proficiency in English and/or Hindi to attend the training and take surveys
  • has received prior in-depth LifeFirst training
  • cannot recruit 36 tobacco users in a six-month period
  • does not work in a setting in which brief advice can be added to the workflow
  • does not deliver care in Greater Mumbai
  • delivers care in Greater Mumbai but does not expect to do so for one year post-training
  • cannot secure institutional signoff to participate and utilize the program in practice
  • does not have an Android smartphone
  • Patient exclusion criteria:
  • not a user of smokeless or smoked tobacco
  • under age 18
  • does not attend the practice of an enrolled practitioner
  • does not have a mobile phone
  • has another member of their household participating in the study
  • is currently participating in any tobacco cessation program (such as through the National Quitline)

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2025

Estimated Enrollment :

4820 Patients enrolled

Trial Details

Trial ID

NCT05234983

Start Date

November 1 2023

End Date

October 1 2025

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Narotam Sekhsaria Foundation

Mumbai, Maharashtra, India, 400 021